Clobot (466100) stock
KOSDAQ · Machinery
As of Nov 16, 11:40 AM KST
- Market cap
- KRW 518.8 billion
- As of Nov 16, 2026
- P/E
- -77.10x
- Latest fiscal year
- P/B
- 9.02x
- Latest reported equity
- P/S
- 11.37x
- Latest fiscal year
- ROE
- -11.7%
- Latest fiscal year
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
- Market cap
- KRW 518.8 billion
- As of Nov 16, 2026
- P/E
- -77.10x
- Latest fiscal year
- P/B
- 9.02x
- Latest reported equity
- P/S
- 11.37x
- Latest fiscal year
- ROE
- -11.7%
- Latest fiscal year
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 16, 2026 · Financial period · Latest fiscal year
Latest fiscal-year financials · Computed in-house by ChickenStock
P/E
-77.10x
Net loss — not comparable
P/B
9.02x
P/S
11.37x
Earnings and dividend metrics▾
Earnings
EPS
-KRW 216
Earnings per share
BPS
KRW 1,845
Book value per share
ROE
-11.7%
Return on equity
- EPS — what one share earned over the last four quarters. The company is currently loss-making, at KRW 216 per share.
- BPS — net assets divided by the number of shares. Each share is backed by KRW 1,845 of net assets.
- ROE — shareholder equity shrank by 11.7% over a year.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from DART financial filings: net income attributable to owners of the parent and revenue are summed over the latest four quarters, equity is the latest reported equity, and prices are KRX closing prices.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Earnings
Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| Q2 2026Consolidated · Filed Aug 14, 2026 | KRW 8.9 billion | -KRW 2.8 billion | -KRW 2.6 billion | +12.9% |
| Q1 2026Consolidated · Filed May 15, 2026 | KRW 8.1 billion | -KRW 2.5 billion | -KRW 2.2 billion | +65.0% |
| Q4 2025Consolidated · Filed Mar 20, 2026 | KRW 17.9 billion | KRW 1.3 billion | — | — |
| Q3 2025Consolidated · Filed Nov 14, 2025 | KRW 10.7 billion | KRW 800 million | KRW 1.1 billion | — |
| Q2 2025Consolidated · Filed Aug 13, 2025 | KRW 7.8 billion | -KRW 1.9 billion | -KRW 1.4 billion | — |
| Q1 2025Consolidated · Filed May 15, 2025 | KRW 4.9 billion | -KRW 3.4 billion | -KRW 3 billion | — |
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| FY2025Consolidated · Filed Mar 20, 2026 | KRW 41.4 billion | -KRW 3.2 billion | — | +24.0% |
| FY2024Consolidated · Filed Mar 26, 2025 | KRW 33.4 billion | -KRW 7.5 billion | -KRW 6.7 billion | — |
- Q2 2026 is computed as H1 2026 minus Q1 2026.
- Q4 2025 is computed as FY2025 minus 9M 2025.
- Q3 2025 is computed as 9M 2025 minus H1 2025.
- Q2 2025 is computed as H1 2025 minus Q1 2025.
Short selling and securities lending
Short sales as a share of trading value, the reported short position and the securities lending balance.
- Short-sale share
- 5.38%
- Of trading value on Nov 13, 2026
- Short-sale value
- KRW 330 million
- Previous 20-day average 7.19%
- Net short position
- 233,424 shares
- As of Nov 11, 2026 · reported with a two-trading-day lag
- Lending balance
- 3,801,343 shares
- As of Nov 13, 2026 · 12.19% of listed shares
| Date | Share | Value |
|---|---|---|
| Nov 13, 2026 | 5.38% | KRW 330 million |
| Nov 12, 2026 | 7.64% | KRW 270 million |
| Nov 11, 2026 | 3.33% | KRW 180 million |
| Nov 10, 2026 | 8.07% | KRW 310 million |
| Nov 9, 2026 | 9.21% | KRW 390 million |
| Nov 6, 2026 | 6.68% | KRW 440 million |
| Nov 5, 2026 | 9.87% | KRW 520 million |
| Nov 4, 2026 | 7.37% | KRW 460 million |
| Nov 3, 2026 | 14.10% | KRW 510 million |
| Nov 2, 2026 | 2.65% | KRW 70 million |
The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.
Filings
Major filings received by DART, Korea’s regulatory filing system.
- Report on Specified Securities Held by Executives and Major ShareholdersOct 12, 2026 · Insider Ownership ReportEnglish
- Report on Major Holdings of Shares (Short Form)(Korean)Sep 9, 2026 · Major Holding Report
- [Amended] Decision on Acquisition of Shares in Another Company(Korean)Aug 31, 2026 · Investment
- Report on Major Holdings of Shares (General Form)(Korean)Aug 28, 2026 · Major Holding Report
- Report on Specified Securities Held by Executives and Major Shareholders(Korean)Aug 28, 2026 · Insider Ownership Report
- Report on Specified Securities Held by Executives and Major Shareholders(Korean)Aug 28, 2026 · Insider Ownership Report
- Report on Specified Securities Held by Executives and Major Shareholders(Korean)Aug 28, 2026 · Insider Ownership Report
- Report on Specified Securities Held by Executives and Major Shareholders(Korean)Aug 28, 2026 · Insider Ownership Report
Filings with a published English version open in English; the rest link to the Korean original.
Clobot (466100) stock information
KOSDAQ
Clobot (466100) is listed on KOSDAQ. Its market capitalization is about KRW 518.8 billion. On trailing-twelve-month earnings the P/E ratio is -77.1, and the P/B ratio is 9.02. Return on equity is -11.7%. These figures are computed in-house from official filings and are reference information only.
Clobot — frequently asked questions
- What is the P/E ratio of Clobot (466100)?
- On a trailing-twelve-month basis, 466100 trades at a P/E ratio of -77.1. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Clobot?
- 466100 has a market capitalization of about KRW 518.8 billion. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.